A MYELOFIBROSIS CASE THAT DEVELOPS MYCOBACTERIUM INFECTION AFTER RUXOLITINIB TREATMENT

被引：0
|
作者：
Malkan, U. [1 ]
Gunes, G. [1 ]
Okay, M. [1 ]
Haznedaroglu, I. [1 ]
机构：
[1] Hacettepe Univ, Sch Med, Dept Hematol, Ankara, Turkey
来源：
LEUKEMIA RESEARCH | 2016年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OP-3
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [21] Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis
    Caocci, G.
    Murgia, F.
    Podda, L.
    Solinas, A.
    Atzeni, S.
    La Nasa, G.
    LEUKEMIA, 2014, 28 (01) : 225 - 227
  • [22] Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis
    G Caocci
    F Murgia
    L Podda
    A Solinas
    S Atzeni
    G La Nasa
    Leukemia, 2014, 28 : 225 - 227
  • [23] Disappearance of fibrosis in secondary myelofibrosis after ruxolitinib treatment: new endpoint to achieve?
    Matteo Molica
    Alessandra Serrao
    Roberta Saracino
    Irene Zacheo
    Christof Stingone
    Giuliana Alimena
    Massimo Breccia
    Annals of Hematology, 2014, 93 : 1951 - 1952
  • [24] Updated recommendations on the use of ruxolitinib for the treatment of myelofibrosis
    Devos, Timothy
    Selleslag, Dominik
    Granacher, Nikki
    Havelange, Violaine
    Benghiat, Fleur Samantha
    HEMATOLOGY, 2022, 27 (01) : 23 - 31
  • [25] A Review of Ruxolitinib for the Treatment of Myelofibrosis: A Critique of the Evidence
    Ros Wade
    Robert Hodgson
    Mousumi Biswas
    Melissa Harden
    Nerys Woolacott
    PharmacoEconomics, 2017, 35 : 203 - 213
  • [26] Disappearance of fibrosis in secondary myelofibrosis after ruxolitinib treatment: new endpoint to achieve?
    Molica, Matteo
    Serrao, Alessandra
    Saracino, Roberta
    Zacheo, Irene
    Stingone, Christof
    Alimena, Giuliana
    Breccia, Massimo
    ANNALS OF HEMATOLOGY, 2014, 93 (11) : 1951 - 1952
  • [27] Definition and management of ruxolitinib treatment failure in myelofibrosis
    Pardanani, A.
    Tefferi, A.
    BLOOD CANCER JOURNAL, 2014, 4 : e268 - e268
  • [28] Ruxolitinib in the treatment of patients with myelofibrosis - questions and answers
    Warzocha, Krzysztof
    Homenda, Wojciech
    Pluta, Andrzej
    Sacha, Tomasz
    Cioch, Maria
    Dudzinski, Marek
    Krochmalczyk, Dorota
    Gora-Tybor, Joanna
    Seferynska, Ilona
    Joks, Monika
    Sobas, Marta
    ONCOLOGY IN CLINICAL PRACTICE, 2019, 15 (03): : 167 - 179
  • [29] Efficacy and safety of ruxolitinib in the treatment of patients with myelofibrosis
    Yi, Cecilia Arana
    Tam, Constantine S.
    Verstovsek, Srdan
    FUTURE ONCOLOGY, 2015, 11 (05) : 719 - 733
  • [30] Review of Treatment Options for Myelofibrosis: Focus on Ruxolitinib
    McLornan, Donal P.
    Laurie, John
    Harrison, Claire N.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2013, 5 : 15 - 24
12345